Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

6.05USD
4:01pm BST
Change (% chg)

$0.05 (+0.83%)
Prev Close
$6.00
Open
$5.95
Day's High
$6.10
Day's Low
$5.95
Volume
18,832
Avg. Vol
187,488
52-wk High
$8.55
52-wk Low
$2.45

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.29 December 24 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 3 3 3 2
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.33

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.23 0.40 0.00 0.80
Quarter Ending Sep-18 3 0.23 0.40 0.00 0.80
Year Ending Dec-18 3 0.87 1.60 0.00 2.00
Year Ending Dec-19 4 1.17 2.10 0.00 2.00
Earnings (per share)
Quarter Ending Jun-18 3 -0.29 -0.28 -0.32 -0.30
Quarter Ending Sep-18 3 -0.31 -0.29 -0.34 -0.30
Year Ending Dec-18 3 -1.23 -1.13 -1.41 -1.20
Year Ending Dec-19 4 -1.36 -1.20 -1.51 -1.34

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.50 0.46 0.04 7.80
Quarter Ending Sep-17 0.40 0.46 0.06 15.75
Quarter Ending Jun-17 0.30 0.46 0.16 54.33
Quarter Ending Mar-17 0.80 0.46 0.34 42.25
Quarter Ending Dec-16 0.40 0.49 0.09 22.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.23 0.23 0.23 0.40 0.80
Quarter Ending Sep-18 0.23 0.23 0.23 0.40 0.80
Year Ending Dec-18 0.87 0.87 0.87 1.15 2.00
Year Ending Dec-19 1.17 1.17 1.17 1.57 2.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings